KENGREAL is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by The Medicines Company. The primary component is Cangrelor.
| Product ID | 65293-003_e16d2568-1d43-420c-a2b4-850f85861271 | 
| NDC | 65293-003 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | KENGREAL | 
| Generic Name | Cangrelor | 
| Dosage Form | Injection, Powder, Lyophilized, For Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2015-07-08 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA204958 | 
| Labeler Name | The Medicines Company | 
| Substance Name | CANGRELOR | 
| Active Ingredient Strength | 50 mg/1 | 
| Pharm Classes | P2Y12 Platelet Inhibitor [EPC],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2015-07-08 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA204958 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2015-07-08 | 
| Marketing End Date | 2019-02-28 | 
| Marketing Category | NDA | 
| Application Number | NDA204958 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2015-07-08 | 
| Marketing End Date | 2019-02-28 | 
| Ingredient | Strength | 
|---|---|
| CANGRELOR | 50 mg/1 | 
| SPL SET ID: | fd5534d0-92c8-41bf-9eca-8259405fbfc2 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 10122-620 | KENGREAL | cangrelor | 
| 65293-003 | KENGREAL | cangrelor | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() KENGREAL  87442665  not registered Live/Pending  | 
        Chiesi Farmaceutici S.P.A.  2017-05-09  | 
![]() KENGREAL  86166110  4867615 Live/Registered  | 
        CHIESI FARMACEUTICI S.P.A.  2014-01-15  |